Does Betaseron (interferon beta-1b) cause side effects?
Betaseron (interferon beta-1b) is an immunological agent made from human proteins used to treat relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
Common side effects of Betaseron include
- flu-like symptoms (fever, tiredness, sweating, chills, muscle aches when you first start to use it),
- low white blood cell count,
- increased liver enzyme,
- problems sleeping,
- increased muscle tension,
- rash, and
- stomach pain.
Serious side effects of Betaseron include
- Heart problems. Symptoms of heart problems include
- Serious skin reactions (severe damage to skin and the tissue below the skin),
- Injection site problems. Symptoms may include
- redness, or pain at the injection site,
- fluid drainage from the injection site, and
- breaks in the skin or blue-black skin discoloration
There are no adequate and well-controlled studies of Betaseron in pregnant women; however, spontaneous abortions while on treatment were reported in four patients participating in the Betaseron RRMS clinical trial. Betaseron should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
It is unknown if Betaseron is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Betaseron, a decision should be made to either discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.
What are the side effects of Betaseron (interferon beta-1b)?
Betaseron may cause serious side effects. Call your healthcare provider right away if you have any of the serious side effects of Betaseron including:
Betaseron may worsen heart problems including congestive heart failure. Symptoms of heart problems may include:
- swollen ankles
- shortness of breath
- not being able to lay flat in bed
- tightness in chest
- decreased ability to exercise
- fast heartbeat
- increased need to urinate at night
- injection site problems.
Serious skin reactions can happen in some people including areas of severe damage to skin and the tissue below the skin (necrosis). These reactions can happen anywhere you inject Betaseron.
Symptoms of injection site problems may include:
- redness, or
- pain at the injection site,
- fluid drainage from the injection site, and
- breaks in your skin or
- blue-black skin discoloration.
Betaseron can cause flu-like symptoms including:
These symptoms may decrease over time. Taking medicines for fever and pain relief on the days you are using Betaseron may help decrease these symptoms.
Some people have had seizures while taking Betaseron, including people who have never had seizures before. It is not known if the seizures were related to their MS, to Betaseron, or to a combination of both.
If you have a seizure after taking Betaseron call your healthcare provider right away. The most common side effects of Betaseron include:
- low white blood cell count
- increases in your liver enzymes
- problems sleeping
- increases in your muscle tension
- stomach pain
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Betaseron. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Betaseron (interferon beta-1b) side effects list for healthcare professionals
The following serious adverse reactions are discussed in more details in other sections of labeling:
- Hepatic Injury
- Anaphylaxis and Other Allergic Reactions
- Depression and Suicide
- Congestive Heart Failure
- Injection Site Necrosis and Reactions
- Thrombotic microangiopathy
- Flu-like Symptom Complex
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions and over varying lengths of time, adverse reaction rates observed in the clinical trials of Betaseron cannot be directly compared to rates in clinical trials of other drugs, and may not reflect the rates observed in practice.
Among 1407 patients with MS treated with Betaseron 0.25 mg every other day (including 1261 patients treated for greater than one year), the most commonly reported adverse reactions (at least 5% more frequent on Betaseron than on placebo) were
- injection site reaction,
- lymphopenia, flu-like symptoms,
- myalgia leukopenia,
- increased liver enzymes,
- abdominal pain, and
The most frequently reported adverse reactions resulting in clinical intervention (for example, discontinuation of Betaseron, adjustment in dosage, or the need for concomitant medication to treat an adverse reaction symptom) were
- flu-like symptom complex,
- injection site reactions,
- increased liver enzymes,
- hypertonia, and
Table 2 enumerates adverse reactions and laboratory abnormalities that occurred among patients treated with 0.25 mg of Betaseron every other day by subcutaneous injection in the pooled placebo-controlled trials (Study 1-4) at an incidence that was at least 2% more than that observed in the placebo-treated patients.
Table 2: Adverse Reactions and Laboratory
Abnormalities in Patients with MS in Pooled Studies 1, 2, 3, and 4
|Blood and lymphatic system disorders|
|Lymphocytes count decreased ( < 1500/mm³)||66%||86%|
|Absolute neutrophil count decreased ( < 1500/mm³)||5%||13%|
|White blood cell count decreased ( < 3000/mm³)||4%||13%|
|Nervous system disorders|
|Respiratory, thoracic and mediastinal disorders|
|Alanine aminotransferase increased (SGPT > 5 times baseline)||4%||12%|
|Aspartate aminotransferase increased (SGOT > 5 times baseline)||1%||4%|
|Skin and subcutaneous tissue disorders|
|Musculoskeletal and connective tissue disorders|
|Renal and urinary disorders|
|Reproductive system and breast disorders|
|General disorders and administration site conditions|
|Injection site reaction1||26%||78%|
|Flu-like symptoms (complex)2||37%||57%|
|Injection site necrosis||0%||4%|
|1 “Injection site reaction”
comprises all adverse reactions occurring at the injection site (except
injection site necrosis), that is, the following terms: injection site
reaction, injection site hemorrhage, injection site hypersensitivity, injection
site inflammation, injection site mass, injection site pain, injection site
edema and injection site atrophy.
2 “Flu-like symptom (complex)” denotes flu syndrome and/or a combination of at least two adverse reactions from fever, chills, myalgia, malaise, sweating.
In addition to the Adverse Reactions listed in Table 2, the following adverse reactions occurred more frequently on Betaseron than on placebo, but with a difference smaller than 2%:
- leg cramps,
- peripheral vascular disorder,
- prostatic disorder,
- urinary frequency,
- vasodilatation, and
- weight increase.
- In the four clinical trials (Studies 1, 2, 3, and 4), leukopenia was reported in 18% and 6% of patients in Betaseron and placebo-treated groups, respectively.
- No patients were withdrawn or dose reduced for neutropenia in Study 1.
- Three percent (3%) of patients in Studies 2 and 3 experienced leukopenia and were dose-reduced.
- Other abnormalities included increase of SGPT to greater than five times baseline value (12%), and increase of SGOT to greater than five times baseline value (4%).
- In Study 1, two patients were dose reduced for increased hepatic enzymes; one continued on treatment and one was ultimately withdrawn.
- In Studies 2 and 3, 1.5% of Betaseron patients were dose-reduced or interrupted treatment for increased hepatic enzymes.
- In Study 4, 1.7% of patients were withdrawn from treatment due to increased hepatic enzymes, two of them after a dose reduction.
- In Studies 1-4, nine (0.6%) patients were withdrawn from treatment with Betaseron for any laboratory abnormality, including four (0.3%) patients following dose reduction.
- As with all therapeutic proteins, there is a potential for immunogenicity.
- Serum samples were monitored for the development of antibodies to Betaseron during Study 1.
- In patients receiving 0.25 mg every other day 56/124 (45%) were found to have serum neutralizing activity at one or more of the time points tested.
- In Study 4, neutralizing activity was measured every 6 months and at end of study.
- At individual visits after start of therapy, activity was observed in 17% up to 25% of the Betaseron-treated patients.
- Such neutralizing activity was measured at least once in 75 (30%) out of 251 Betaseron patients who provided samples during treatment phase; of these, 17 (23%) converted to negative status later in the study.
- Based on all the available evidence, the relationship between antibody formation and clinical safety or efficacy is not known.
- These data reflect the percentage of patients whose test results were considered positive for antibodies to Betaseron using a biological neutralization assay that measures the ability of immune sera to inhibit the production of the interferoninducible protein, MxA.
- Neutralization assays are highly dependent on the sensitivity and specificity of the assay.
- Additionally, the observed incidence of neutralizing activity in an assay may be influenced by several factors including sample handling, timing of sample collection, concomitant medications, and underlying disease.
- For these reasons, comparison of the incidence of antibodies to Betaseron with the incidence of antibodies to other products may be misleading.
- Anaphylactic reactions have been reported with the use of Betaseron.
The following adverse reactions have been identified during postapproval use of Betaseron. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
- Blood and lymphatic system disorders: Anemia, Thrombocytopenia
- Endocrine disorders: Hypothyroidism, Hyperthyroidism, Thyroid dysfunction
- Metabolism and nutrition disorders: Triglyceride increased, Anorexia, Weight decrease, Weight increase
- Psychiatric disorders: Anxiety, Confusion, Emotional lability
- Nervous system disorders: Convulsion, Dizziness, Psychotic symptoms
- Cardiac disorders: Cardiomyopathy, Palpitations, Tachycardia
- Vascular disorders: Vasodilatation
- Respiratory, thoracic and mediastinal disorders: Bronchospasm
- Gastrointestinal disorders: Diarrhea, Nausea, Pancreatitis, Vomiting
- Hepatobiliary disorders: Hepatitis, Gamma GT increased
- Skin and subcutaneous tissue disorders: Alopecia, Pruritus, Skin discoloration, Urticaria
- Musculoskeletal and connective tissue disorders: Arthralgia
- Reproductive system and breast disorder: Menorrhagia
- General disorders and administration site conditions: Fatal capillary leak syndrome*
*The administration of cytokines to patients with a pre-existing monoclonal gammopathy has been associated with the development of this syndrome.
Betaseron (interferon beta-1b) is an immunological agent made from human proteins used to treat relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Common side effects of Betaseron include flu-like symptoms (fever, tiredness, sweating, chills, muscle aches when you first start to use it), low white blood cell count, increased liver enzyme, problems sleeping, headache, increased muscle tension, weakness, pain, rash, and stomach pain. Betaseron should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is unknown if Betaseron is excreted in human milk.
Multimedia: Slideshows, Images & Quizzes
Multiple Sclerosis (MS) Quiz: Test Your Medical IQ
Multiple Sclerosis is a debilitating neurological condition. Take the MS Quiz to test your knowledge of the causes, symptoms,...
Picture of Multiple Sclerosis Symptoms
Symptoms of multiple sclerosis may be single or multiple and may range from mild to severe in intensity and short to long in...
What Is Multiple Sclerosis? MS Symptoms, Causes, Diagnosis
MS is an autoimmune disease that attacks the nerves of the central nervous system. Learn about multiple sclerosis (MS) causes,...
What You Should Know About Multiple Sclerosis
Learn about celebrities, such as Montel Williams and Jack Osbourne, who are living with multiple sclerosis.
Multiple Sclerosis: Making an MS Friendly Home
Adults with multiple sclerosis may be at risk for injuries, hazards, and falling at home. Some simple home modifications can...
Related Disease Conditions
Multiple Sclerosis (MS) Symptoms, Causes, Treatment, Life Expectancy
Multiple sclerosis or MS is an autoimmune disorder in which brain and spinal cord nerve cells become demyelinated. This damage results in symptoms that may include numbness, weakness, vertigo, paralysis, and involuntary muscle contractions. Different forms of MS can follow variable courses from relatively benign to life-threatening. MS is treated with disease-modifying therapies. Some MS symptoms can be treated with medications.
Alternative Treatment for MS (CAM for MS)
The term alternative therapy, in general, is used to describe any medical treatment or intervention that has not been scientifically documented or identified as safe or effective for a specific condition. Alternative therapy encompasses a variety of disciplines that range from diet and exercise to mental conditioning to lifestyle changes.
Multiple Sclerosis (MS)
Multiple sclerosis (MS) symptoms vary from person to person, and can last for days to months without periods of remission. Symptoms of MS include sexual problems and problems with the bowel, bladder, eyes, muscles, speech, swallowing, brain, and nervous system. The early symptoms and signs of multiple sclerosis usually start between age 20 and 40. MS in children, teens, and those over age 40 is rare. Treatment options for multiple sclerosis vary depending on the type and severity of symptoms. Medications may be prescribed to manage MS symptoms.
Is MS Contagious? (Multiple Sclerosis)
Multiple sclerosis, or MS, is a degenerative disease of the covering around the nerves in the central nervous system (CNS). Researchers and doctors don't know the exact cause, but many theorize that it may be due to environmental triggers, an autoimmune disease, and viruses (infections). Symptoms of MS include vision changes, paralysis, vertigo, heat intolerance, slurred speech, sexual dysfunction, and urinary incontinence (the inability to urinate). There's no vaccine or cure for MS, but the progression and symptoms of the disease can be treated.
MS (Multiple Sclerosis) vs. ALS (Amyotrophic Lateral Sclerosis) Differences and Similarities
ALS (amyotrophic lateral sclerosis, Lou Gehrig's disease) and MS (multiple sclerosis) are both diseases of the nervous system (neurodegenerative). ALS is a disease in which the nerve cells in the body are attacked by the immune system, although it's not considered an autoimmune disease by some scientists. MS is an autoimmune disease in which the insulated covering of the nerves (myelin sheath) in the CNS (central nervous system) degenerate, or deteriorate. Scientists don't know the exact cause of either problem. However, they have discovered that mutations in the gene that produces the SOD1 enzyme were associated with some cases of familial ALS. Scientists also theorize that multiple sclerosis may be caused by infection or vitamin D deficiency. ALS occurs between 50-70 years of age (the average age of occurrence ALS is 55), and mostly affects men. While MS occurs between 20-60 years of age, and mostly affects women. About 30,000 people in the US have ALS, and an average of 5,000 new diagnoses per year (that's about 15 new cases per week). Worldwide, MS affects more than 2.3 million people, with about 10,000 new cases diagnosed each year (that's about 200 new diagnoses per week).Some of the signs and symptoms of both diseases include muscle weakness, muscle spasms, problems walking, fatigue, slurred speech, and problems swallowing. ALS signs and symptoms that are different from MS include problems holding the head upright, clumsiness, muscle cramps and twitches, problems holding objects, and uncontrollable periods of laughing or crying. MS signs and symptoms that are different from ALS include vision problems, vertigo and balance problems, sexual problems, memory problems, depression, mood swings, and digestive problems. There is no cure for either disease, however the prognosis and life expectancy are different. Multiple sclerosis is not a fatal condition, while ALS progresses rapidly and leads to death.
Multiple Sclerosis (MS) and Pregnancy
Multiple sclerosis or MS is a central nervous system disease in which the immune system attacks the myelin sheath (the protective coating around nerves). Symptoms of MS include pain, sexual problems, fatigue, numbness and tingling, emotional changes, and depression.Women who are pregnant and have multiple sclerosis may have more difficulty carrying a pregnancy. Multiple sclerosis does not affect ability to conceive, and does not seem to affect fertility. MS symptoms during pregnancy may stay the same or get better; however, they may worsen after giving birth. Pregnancy decreases the number of relapses, but flares increase in the first 3-6 months after delivery. Pregnant women with MS may carrying a pregnancy more difficult to tell when labor starts, and there is an increased need to use forceps or vacuum to assist with delivery or b7 C-section (Cesarean birth) increases. Some treatment MS drugs may be safe to use during pregnancy; however, some drugs should not be taken, for example, baclofen (Gablofen, Lioresal), fluoxetine (Prozac, Sarafem), or solifenacin succinate (VESIcare), and most disease-modifying therapies (DMTs). Talk with your healthcare team about vitamins, supplements, and medications that you are taking if you are pregnant and have MS.
Multiple Sclerosis (MS) Early Warning Signs and Types
Multiple sclerosis (MS) can be thought of as an immune-mediated inflammatory process involving different areas of the central nervous system (CNS) at various points in time. Early warning signs and symptoms of MS in children, teens, and adults are similar; however, children and teens with pediatric also may have seizures and a complete lack of energy. Adults with MS do not have these signs and symptoms. Other signs and symptoms of MS include inflammation of the optic nerve (optic neuritis), changes in vision, Wiping or having tissues around the eye and moving the eye may be painful, and double vision. There are four types of MS, relapsing remitting MS (RRMS), secondary progressive MS (SPMS), primary progressive MS (PPMS), and progressive relapsing MD (PRMS).
Can Stress Cause Multiple Sclerosis (MS)?
Multiple sclerosis (MS) results when your immune system attacks the cells of the brain and spinal cord. It is an autoimmune disease, a condition in which the body’s immune system is misdirected and attacks its own cells. Stress can make it difficult for a person to manage MS symptoms. Regular exercise and mindful eating have been found to control the stress levels and overall health of people with MS.
What Are the Very First Signs of Multiple Sclerosis?
Multiple sclerosis (MS) is an inflammatory, neurodegenerative, and autoimmune disease that affects the brain and spinal cord of the central nervous system (CNS). MS is one of the most common causes of non-injurious disability in young and middle-aged adults.
What Are the Early Signs of Multiple Sclerosis?
Multiple sclerosis is an autoimmune disease in which the immune system attacks the central nervous system (spinal cord and brain) by damaging and destroying the protective myelin sheath around the nerve fibers. Someone with multiple sclerosis might develop problems with muscle control, vision, bladder control and other body functions.
Treatment & Diagnosis
Medications & Supplements
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.